Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 25 member 19 (SLC25A19) is a mitochondrial transporter protein embedded in the inner mitochondrial membrane. It primarily functions as the mitochondrial thiamine pyrophosphate (ThPP) carrier, importing ThPP into the mitochondrial matrix. This transport is essential for the activity of ThPP-dependent enzymes, such as the α-ketoglutarate dehydrogenase complex, which is vital for mitochondrial energy metabolism in the citric acid (Krebs) cycle. Genetic loss-of-function mutations in SLC25A19 cause devastating metabolic diseases, including Amish lethal microcephaly—characterized by severe congenital microcephaly, α-ketoglutaric aciduria, and neonatal lethality due to impaired mitochondrial function and abnormal brain development[1][2][4][6]. The protein was previously thought to function as a deoxynucleotide carrier, but its primary physiological role is now recognized as ThPP transport[2][6]. No drugs are currently known to target SLC25A19 directly.
Not applicable; no known drugs with a defined mechanism of action targeting SLC25A19 transporter.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 25 member 19 (SLC25A19).